At a recent Nasdaq webinar on the future of climate investing, three leading analysts discussed the current state of climate investing, data’s role in the evolving landscape and how to hold institutional investors and companies accountable for their ambitious climate agendas.
At Ericsson, we believe limitless connectivity can help pioneer a sustainable future.
The European Society of Medical Oncology (ESMO) annual congress convened earlier this month in Paris, where, Illumina presented key abstracts demonstrating the clinical utility of comprehensive genomic profiling (CGP). CGP is a next-generation sequencing (NGS) approach that uses a single test to assess hundreds of genes—including relevant cancer biomarkers, as established in medical guidelines and clinical trials—for tumor therapy guidance.